AlphaQuest LLC Grows Position in Humana Inc. $HUM

AlphaQuest LLC increased its position in shares of Humana Inc. (NYSE:HUM) by 126.1% during the 1st quarter, Holdings Channel.com reports. The fund owned 1,422 shares of the insurance provider’s stock after acquiring an additional 793 shares during the period. AlphaQuest LLC’s holdings in Humana were worth $376,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of HUM. Cary Street Partners Investment Advisory LLC lifted its stake in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after acquiring an additional 46 shares in the last quarter. Riverview Trust Co acquired a new position in Humana during the 1st quarter worth about $34,000. Garde Capital Inc. acquired a new position in Humana during the 1st quarter worth about $36,000. Zions Bancorporation National Association UT acquired a new position in Humana during the 1st quarter worth about $37,000. Finally, Whipplewood Advisors LLC lifted its stake in Humana by 639.1% during the 1st quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider’s stock worth $45,000 after acquiring an additional 147 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on HUM shares. Wells Fargo & Company decreased their target price on Humana from $348.00 to $344.00 and set an “overweight” rating on the stock in a research note on Thursday, August 14th. Truist Financial reduced their price target on Humana from $280.00 to $260.00 and set a “hold” rating on the stock in a research report on Wednesday, July 16th. Bank of America reduced their price target on Humana from $320.00 to $260.00 and set a “neutral” rating on the stock in a research report on Tuesday, June 17th. Barclays set a $275.00 price target on Humana and gave the company an “equal weight” rating in a research report on Thursday, July 31st. Finally, Oppenheimer increased their price target on Humana from $300.00 to $310.00 and gave the company an “outperform” rating in a research report on Thursday, May 1st. Seven research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $283.29.

Humana Price Performance

Shares of NYSE HUM opened at $297.30 on Thursday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $382.72. The firm has a market capitalization of $35.76 billion, a PE ratio of 22.82, a price-to-earnings-growth ratio of 1.76 and a beta of 0.44. The stock’s 50-day simple moving average is $252.05 and its 200-day simple moving average is $254.08.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The business had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.Humana’s revenue was up 9.6% on a year-over-year basis. During the same period last year, the business posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Friday, September 26th. Humana’s dividend payout ratio (DPR) is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.